Virus News and Research

Latest Virus News and Research

Scientists develop chip for detection of RNA strand of dengue fever virus

Scientists at the Center for Research and Advanced Studies (Cinvestav) in Mexico developed a chip (also known as cDNA microarray) that allows detection of the RNA strand of the dengue fever virus.

7 Jul 2014

Research roundup: 20M gain insurance, coverage's effect on surgery choices; opioid use by service members

This report aims to help readers understand recently announced enrollment numbers, as well as other numbers that have received less attention, and assess their importance for the future of the ACA and our health care system. .

4 Jul 2014

Multicenter trial aims to find safety, effectiveness of probiotics in infants with stomach flu

Consumers worldwide spend billions of dollars each year on probiotic foods and supplements. But studies evaluating probiotics - microorganisms believed to aid digestive health - have been limited.

4 Jul 2014

Scientists produce drug compound with potential to block HIV transmission in women

Scientists at the University of Nebraska-Lincoln College of Engineering's Biological Process Development Facility have successfully produced a drug compound with potential to block HIV transmission in women.

4 Jul 2014

Researchers discover how metal beryllium triggers deadly immune response in the lungs

Using exquisitely detailed maps of molecular shapes and the electrical charges surrounding them, researchers at National Jewish Health have discovered how the metal beryllium triggers a deadly immune response in the lungs.

3 Jul 2014

Viewpoints: Court complicates women's health care; decouple work and coverage; Cuomo's fight against AIDS

The 5-4 decision, which runs 89 pages (including a 35-page dissent), is a messy, sprawling affair. The majority insists that its reach is narrow, while the dissent holds otherwise. What's clear is that the ruling will needlessly complicate not only constitutional and corporate law but also -- at least as significant -- health care for women who work at such companies (6/30).

3 Jul 2014

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.

3 Jul 2014

New meta-analysis highlights significant gaps in hepatitis C care

A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs.

3 Jul 2014

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Isis Pharmaceuticals, Inc. announced today that it has earned a $1 million payment from GlaxoSmithKline related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV).

2 Jul 2014

MedImmune initiates MEDI8897 phase I clinical studies for treatment of RSV infections

AIMM Therapeutics, a leading human therapeutic antibody company, today announced that its partner MedImmune, LLC, the global biologics unit of AstraZeneca, has initiated phase I clinical studies with MEDI8897, a best-in-class antibody for the treatment of respiratory syncytial virus (RSV) infections in young, at risk children.

2 Jul 2014

N.Y. governor unveils plan to fight HIV

The goal, the governor says, is to reduce new HIV infections to 750 per year by 2020 through aggressive treatment and testing.

1 Jul 2014

New estimates highlight the importance of developing norovirus vaccines

Noroviruses are a leading cause of acute gastroenteritis (diarrhoea and vomiting) across all age groups, responsible for almost a fifth (18%) of all cases worldwide. New estimates, published in The Lancet Infectious Diseases, highlight the importance of developing norovirus vaccines, say the authors.

28 Jun 2014

Lassa virus uses two-step process to invade cells, shows study

Scientists have discovered that the Lassa virus, which is endemic to West Africa, uses an unexpected two-step process to enter cells.

28 Jun 2014

EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.

27 Jun 2014

Noroviruses responsible for almost a fifth of all cases of acute gastroenteritis

27 Jun 2014

WHO convenes experts for operational response to 2014 Ebola outbreak in West Africa

The emergence of an Ebola virus disease outbreak in West Africa in 2014 has become a challenge to the 3 countries involved, as the Governments of Guinea, Liberia and Sierra Leone work intensively with WHO and other partners to ramp up a series of measures to control the outbreak.

27 Jun 2014

Virus News and Research

Latest Virus News and Research

Scientists develop chip for detection of RNA strand of dengue fever virus

Research roundup: 20M gain insurance, coverage's effect on surgery choices; opioid use by service members

Multicenter trial aims to find safety, effectiveness of probiotics in infants with stomach flu

Scientists produce drug compound with potential to block HIV transmission in women

Researchers discover how metal beryllium triggers deadly immune response in the lungs

Viewpoints: Court complicates women's health care; decouple work and coverage; Cuomo's fight against AIDS

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

New meta-analysis highlights significant gaps in hepatitis C care

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

MedImmune initiates MEDI8897 phase I clinical studies for treatment of RSV infections

N.Y. governor unveils plan to fight HIV

New estimates highlight the importance of developing norovirus vaccines

Lassa virus uses two-step process to invade cells, shows study

EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

Noroviruses responsible for almost a fifth of all cases of acute gastroenteritis

WHO convenes experts for operational response to 2014 Ebola outbreak in West Africa

Longer looks: Women caregivers giving up careers; 'Buyers Club' laws; finding a voice for the patient

New article explores how specific types of interferons control RNA virus infection

Cancer drug shows promise in treating blood cell disorders

Interactions with other infections can trigger herpes virus to reactivate, shows research

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in